In my very first MannKind article I offered for my SA readers, I made the following statement:
Wall Street gurus are always smarter than the retail investor that doesn’t do their homework.
I have mentioned several times that MannKind’s (NASDAQ:MNKD) management understands the reality and has done a remarkable job in keeping the company hooked up to a life support system that has allowed them to be one of the few (other than the short-sellers) to benefit from these four years of futility for the retail investors. In recent days, with the flurry of superfluous SEC filings and press releases this has only resulted in the stock falling to a near all-time low price. The time is neigh for this saga becoming history so we can close the books on this financial fiasco. It’s now clear who has done their homework on MannKind!
Best Low Price Stocks To Own Right Now: Sorrento Therapeutics, Inc.(SRNE)
- [By ]
In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .
- [By William Romov]
San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.
On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”
- [By ]
Sorrento Therapeutics (SRNE) : “This is the kind of speculative stock that I like.”
Geron (GERN) : “Let’s stick with high quality like Thermo Fisher Scientific (TMO) .”
Best Low Price Stocks To Own Right Now: Goldfield Corporation (GV)
- [By Jim Robertson]
Just before Thanksgiving, our Under the Radar Moversnewsletter suggested buying small cap electrical infrastructure stockGoldfield Corp (NYSEMKT:GV):
Best Low Price Stocks To Own Right Now: Gas Natural Inc.(EGAS)
- [By Monica Gerson]
Gas Natural Inc (NYSE: EGAS) is projected to post its quarterly earnings at $0.23 per share.
Caleres Inc (NYSE: CAL) is expected to post its quarterly earnings at $0.23 per share on revenue of $632.89 million.